Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$1.99 - $3.1 $1.99 Million - $3.1 Million
-999,364 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$10.92 - $18.18 $3,276 - $5,454
-300 Reduced 0.03%
999,364 $18 Million
Q2 2018

Aug 02, 2018

SELL
$10.0 - $17.87 $3,360 - $6,004
-336 Reduced 0.03%
999,664 $15.1 Million
Q4 2017

Feb 05, 2018

BUY
$8.48 - $12.0 $8.48 Million - $12 Million
1,000,000
1,000,000 $9.76 Million

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Omega Fund Management, LLC Portfolio

Follow Omega Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omega Fund Management, LLC with notifications on news.